Proximity to clinical care and time to resolution following an abnormal cancer screening in an urban setting by Han, Ann M.
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2013
Proximity to clinical care and time
to resolution following an abnormal
cancer screening in an urban
setting
https://hdl.handle.net/2144/12113
Boston University
BOSTON UNIVERSITY 
SCHOOL OF PUBLIC HEALTH 
Thesis 
PROXIMITY TO CLINICAL CARE AND TIME 
TO RESOLUTION FOLLOWING AN ABNORMAL 
CANCER SCREENING IN AN URBAN SETTING 
by 
ANNM.HAN 
A.B., Smith College, 1991 
Submitted in patiial fulfillment of the 
requirements for the degree of 
Master of Science 
2013 
© 2013 by 
ANNM.HAN 
All rights reserved 
First Reader 
Second Reader 
Third Reader 
Approved by 
Tr 
edicine and Epidemiology 
Karen M. Freund, ,/MPH 
Professor of Medic1nl~.nd Epidemiology 
Veronica Vieira, Ph.D. 
Adjunct Associate Professor 
PROXIMITY TO CLINICAL CARE AND TIME 
TO RESOLUTION FOLLOWING AN ABNORMAL 
CANCER SCREENING IN AN URBAN SETTING 
ANNM.HAN 
ABSTRACT 
Barriers to care have been identified as a major factor in cancer health disparities. 
Previous research at Boston Medical Center (BMC) found that women referred from 
community health centers (CHCs) following abnormal breast cancer screening took 
longer to achieve diagnostic resolution than women referred from a BMC-based practice, 
consistent with research showing longer delays and worse outcomes for disadvantaged 
urban populations. It is not known whether this difference relates to the additional 
distance to BMC. To evaluate the effect of proximity from subjects' residence to the site 
of clinical care on time to diagnostic resolution in this urban setting we conducted a 
secondary analysis using data collected as part of the Boston Patient Navigation Research 
Program (PNRP). The database included all women who had a breast or cervical cancer 
screening abnormality at six Federally-qualified CHCs from January 2007 to June 2009. 
Using geocoded home address data captured at the time of registration, we calculated 
straight-line distances to the location of the diagnostic evaluation, which was the CHC for 
subjects with a cervical abnormality or BMC for subjects with a breast abnormality, and 
plotted the time to diagnostic resolution versus distance to site of care. We used 
proportional hazards regression models to examine the effect of distance to site of care on 
time to resolution, adjusting for CHC, subject age, race/ethnicity, language, and insurance. 
IV 
Results. We geocoded addresses for 1512 of 1544 subjects (98%). Among the diverse 
group of subjects with a breast screening abnormality (36% Black, 33% Hispanic; 44% 
non-English speaking), there was no significant difference in adjusted hazard ratios based 
on distance to care in 1,000 meter units (adjusted Hazard Ratio 1.00, 95% CI 0.99 -1.01). 
Similarly, among those with a cervical screening abnormality (22% Black, 21% 
Hispanic; 15% non-English), there was no significant difference in adjusted hazard ratios 
based on distance to care in 1,000 meter units (adjusted Hazard Ratio 1.01, 95% CI 1.00-
1.02). 
Conclusions. Increased distance between residence and clinic alone is not a barrier to 
diagnostic resolution for this vulnerable urban population receiving care at a CHC who 
had an abnormal cancer screening exam. 
v 
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Introduction 
Cervical and breast cancer disparities are marked by higher mortality rates for racial, 
ethnic and economically disadvantaged women compared to non-Hispanic, non-poor, 
white women. (1-5). Nationally and within Massachusetts, black women present with 
advanced breast cancer more often and suffer higher mortality rates than non-Hispanic 
white women according to the most recent American Cancer Society analysis of data 
collected by the Nation Cancer Institute (NCI) Surveillance, Epidemiology, and End 
Results (SEER) program and state-specific incidence rates and proportion of breast 
cancers diagnosed at in situ and regional/distant stages from the North American 
Association of Central Cancer Registries (NAACR) ( 1 ). Disparities have also been 
observed for women with cervical cancer with studies showing that, particularly for 
middle aged and older black women, mortality rates exceed those of non-Hispanic white 
women(3) and that black women are more likely to die of cervical cancer than non-
Hispanic white women even when adjusting for disease stage (5). 
These breast cancer and cervical cancer health disparities have been documented since 
the SEER program data began collecting and publishing data in the mid 1970's(6, 7). 
Initial efforts to address these disparities focused on access to screening. However, since 
2001 parity has been achieved for cervical cancer screening rates and exceeded for 
mammographic screening rates in Massachusetts (1, 8). More recent efforts feature an 
expanded focus to reducing/removing ban-iers to cancer care from screening, to 
diagnosis, and treatment (9-11 ). 
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Disparities attributable to delayed uptake of preventative, diagnostic and therapeutic 
cancer care have been have been observed due to barriers or obstacles to accessing cancer 
care (1-5). As early as 1989, reports recognized the increased barriers to cancer care 
suffered by disadvantaged populations to include increased suffering, having to make 
personal sacrifices to get care, insufficient health insurance, reluctance to seek care that 
they can not pay for, and not having access to culturally relevant cancer education 
programs(12). Barriers to care identified through door-to-door interviews in 
neighborhoods targeted to oversample non-elderly urban disadvantaged populations 
include lack of knowledge of discounted or free health care programs and difficulty 
finding childcare, getting time off from work, having transportation, or paying for 
healthcare (13). Lack oftransportation as a barrier to healthcare has been identified to 
particularly affect urban residents and unemployed persons (13 , 14). However, the effect 
of distance on access to healthcare has mostly been studied in the context of rural 
populations and rarely with longitudinal data associated with individual outcomes(lS-24). 
Previous studies of disadvantaged urban subjects seeking diagnostic resolution for an 
abnormal breast cancer screening at Boston Medical Center (BMC), the largest safetynet 
institution in New England, identified that women referred to BMC from a community 
health center were significantly less likely than women referred from a hospital-based 
practice to have timely diagnostic care(25). To assess the effect of proximity of home 
address to site of diagnostic care on time to diagnostic resolution of breast and cervical 
screening abnormalities we conducted a secondary database analysis of the Boston 
Patient Navigation Research Program (PNRP). The Boston PNRP is a patient-navigation 
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intervention study conducted in six Federally-qualified community health centers (CHCs) 
of women with an abnormal breast or cervical screening who were referred to either the 
CHC for diagnostic evaluation of a cervical abnormality or to an academic hospital for 
diagnostic evaluation of a breast abnormality at a specialty breast clinic(26). We 
hypothesized that subjects who live closer to their site of care would have a shorter time 
to diagnostic resolution of screening abnormalities compared to subjects who live farther 
from site of care. 
Theoretical Model 
The theoretical model for this study builds on the Andersen' s behavioral model of health 
services use(27) in which a person's need for health care is moderated by their perceived 
needs represented by the referral for diagnostic care following an abnormal cancer 
screening, predisposing characteristics represented by their demographic and community 
traits and enabling factors, represented by proximity to care. 
Methods 
We conducted a secondary analysis of the control arm of the Boston Patient Navigation 
Research Program (PNRP) data to assess the effect of proximity to clinic on time to 
diagnostic resolution after an abnormal cancer screening test. The Boston PNRP is a 
quasi-experimental intervention study of patient navigation as a standard of care to 
reduce barriers to care and improve time to diagnosis and treatment for patients with an 
abnormal breast or cervical cancer screening test(l 0, 26) Data for the Boston PNRP was 
collected between 2007 and 2010 from six, federally-qualified mban community health 
centers. According to the Boston PNRP study design each community health center was 
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purposefully allocated either a breast or cervical navigator because each serves different 
ethnic communities. Breast subjects from community health centers assigned a cervical 
navigator served as controls for comparison to breast subjects from community health 
centers assigned a breast navigator, and vice versa. Subjects were followed for 365 days, 
and observations were censored when diagnostic resolution was achieved. The Boston 
PNRP study was approved by the Boston University Internal Review Board with a 
waiver of written informed consent. 
Study Population. The Boston PNRP study population included all women who had 
presented to one of the six participating federally qualified community health centers 
located within the greater Boston area for breast or cervical cancer screening and whose 
test results were abnormal during either the baseline (2004-5) or intervention period 
(2007 -9). Abnormal breast cancer screening tests included: a clinical breast exam or 
mammogram with breast imaging reporting and data system (BIRADS) assessment 
categories 0 (incomplete), 3 (probably benign), 4(suspicious abnormality), or 5 (highly 
suggestive of malignancy). Abnormal cervical screening tests included: a Pap test with 
results indicating either low-grade abnmmalities (Low Grade Squamous Intraepithelial 
Lesion (LGSIL), or Atypical Squamous Cells of Unknown Significance (ASCUS) 
Human papillomavirus (HPV) positive) or high-grade abnormalities (High Grade 
Squamous Intraepithelial Lesion (HGSIL) or Atypical Glandular Cells of Undetermined 
Significance (AGUS)). 
Exclusion criteria included pregnancy at the time of the screening abnormality, cognitive 
abnormalities that would preclude interaction with a patient navigator, and subjects aged 
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18-21 with a low grade Pap test (ASCUS HPV positive and LGSIL) abnormality whose 
clinician chose repeat pap tests rather than colposcopy following guideline changes in 
2007. Subjects from the intervention arm (navigated subjects) were excluded from this 
study. 
Data Collection. Data for the Boston PNRP was collected both electronically and 
through medical record abstraction. Socio-demographic data including self-report of 
address, date of birth, gender, race/ethnicity, marital status, primary language, and health 
insurance collected during registration was captured from the electronic registration and 
billing system database SDK®. Clinical data including ICD-9 billing codes, date and 
result of index screening abnormality were collected from the electronic medical records 
at each Community Health Center. Additional data regarding clinical decisions and 
diagnostic results were collected onto a standard abstraction form by trained abstractors 
who used a 180-page manual to guide manual chart abstraction. Additionally, 10% of 
charts were reviewed for accuracy of abstraction. All cancer diagnoses, stages and 
treatments were adjudicated by two physicians blinded to the allocation arm of the study. 
Geospatial data for the state of Massachusetts was downloaded from the MassGIS 
website, http://www.mass.gov/mgis/download.htm and included the: 
• 2000 US Census town shapefile, http://www.mass.gov/mgis/cen2000 towns.htm 
which was used to create the base map of Massachusetts. 
• 2009 acute care hospital shapefile, http://www.mass.gov/mgis/hospitals.htm 
which was used to project Boston Medical Center onto the base map. 
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• 2007 Community Health Center shapefile, http://www.mass.gov/mgis/chcs.htm 
which was used to project the CHCs onto the base map. 
• 2000 US Census Tract , http://www.mass.gov/anf/research-and-tech/it-serv-and-
support/application-serv/office-of-geographic-information-
massgis/datalayers/cen2000tracts.html, which was used to project census track 
polygons onto the base map. 
• 2010 U.S. Census- Tiger Roads, http: //www.mass.gov/anf/research-and-tech/it-
serv-and-support/application-serv/office-of-geographic-information-
massgis/datalayers/census2010.html, which was used to project roads onto the 
basemap and served as the data source from which the geolocator file was created 
to geocode subject addresses. 
• MBTA Rapid Transit, http://www.mass.gov/anf/research-and-tech/it-serv-and-
support/application-serv/office-of-geographic-information-
massgis/datalayers/mbta.html, which was used to project the MBTA subway and 
rapid transit bus (silver line) paths and stations onto the base map. 
• MBTA Bus Routes and Stops, http: //www.mass.gov/anf/research-and-techlit-
serv-and-support/application-serv/office-of-geographic-information-
massgis/datalayers/mbtabus.html, which was used to project the MBTA bus 
routes and bus stops onto the base map. 
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All shapefiles were projected in the Lambert Conformal Conic method using NAD 1983 
StatePlane Massachusetts Mainland FIPS 2001 coordinate system and the unit of measure 
was in meters. All analyses were conducted using meters as the unit of measure; 
however, for ease of recognition we converted the units into miles to report our fmdings. 
Using ArcGIS® software by Esri, version 10.0 Service Pack 3 (Build 3600), we 
geocoded the subject home addresses using US address, dual range locator style and the 
TIGER/Line® 2010 census road data. 
Dependent Measures. The outcome variable, time to diagnostic resolution of the 
screening abnormality was defined as the time from the date of the initial screening 
abnormality to the date where the final diagnostic test or evaluation was completed. This 
usually included colposcopy for cervical abnormalities. For breast screening 
abnormalities, this included either a biopsy confirmed diagnosis, additional imaging 
classified as BIRADS 1 or 2, or a clinical determination that the findings were benign. 
Where the initial mammogram result was BIRADS3 and a short interval follow up would 
be recommended (i.e., 6-month reimaging), the next imaging was considered the 
definitive diagnosis. To allow for direct comparison between the BIRADS3, which 
includes a 6-month delay before additional screening, and the other screening 
abnormalities, 180 days was subtracted from the number of days to repeat imaging. If the 
repeat imaging was completed before 180 days, the number of days to diagnostic 
resolution was set to 0 to avoid using a negative number. 
Independent Measures. The distance to care variable was created using spatial analysis 
with ArcGIS® software by Esri, version 10.0 Service Pack 3 (Build 3600), by 
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determining straight line, point to point distances from the subject's geocoded residence 
to the site of diagnostic care. Because of resource availability the site of diagnostic care 
varied by type of screening abnormality. None of the CHCs had diagnostic 
mammography services available on site. Thus, for breast subjects Boston Medical 
Center was used as the site of diagnostic care while for cervical subjects the Community 
Health Center where they sought care was used as the site of diagnostic care. 
Co-variates. Subject demographic information including age, race/ethnicity, primary 
spoken language, type of insurance coverage, site of care, and type of index screening 
abnormality (high versus low grade) was collected from the electronic medical record as 
described above. The variable for percent of census tract population living below Federal 
Poverty Level, a proxy for socio-economic status, was created using data from the 
American Community Service (ACS) census data for Boston for 2000, which was 
spatially matched to each subject living within the respective census tract using ArcGIS® 
software by Esri, version 10.0 Service Pack 3 (Build 3600) for the breast and cervical 
subjects. 
Analyses. Plots of distance to site of care in miles versus time to diagnosis in days were 
prepared using Microsoft Excel separately for cervical and breast screening control 
subjects to assess for a linear relationship. In addition, Cox proportional hazards 
regression models were calculated (SAS 8.2, Statistical Analyst Systems, Cary, North 
Carolina) to examine the effect of distance and time to diagnostic resolution, with 
separate models for the breast and cervical screening subjects. Potential confounders 
included in the models were age, race, primary spoken language, type of insurance, and 
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percentage of census tract population living below Federal Poverty Level, accounting for 
clustering by health center. For these models, hazard ratios > 1 represented more timely 
diagnostic resolution. 
Results 
Of the 1,544 subjects, 1,522 addresses were input for geocoding. The 22 addresses that 
were omitted included 18 post office box addresses, which may not reflect area of 
residence and four street addresses overwritten to indicate the subject had died or that the 
address was "bad". Ofthe 1,522 addresses input for geocoding, 1428 were geocoded with 
a match score greater than 75, indicating a strong match. The 94 addresses with a match 
score less than 75 were confrrmed using Google Maps™. After correcting simple 
spelling errors (ex. Estabrook to Esterbrook), abbreviations (ex. Msgr to Monsignor), and 
adjustments from neighborhood names to city (ex. Dorchester to Boston) an additional 84 
addresses were geocoded by interactively rematching addresses. The remaining 1 0 
addresses include five addresses located outside of Massachusetts (2 in Florida, 1 in New 
Hampshire, 1 in New York, and 1 in Michigan) and five addresses for which insufficient 
information was available to interactively rematch with confidence (ex. 20 Maple in a 
location with both a Maple Street and a Maple A venue). The final dataset included 1512 
geocoded address for the 1544 subjects (98%) representing 962 breast and 550 cervical 
subjects. 
Subject characteristics. Table 1 displays the sociodernographic characteristics for both 
the breast and cervical subjects enrolled into the control arm for the Boston PNRP. The 
demographic characteristics ofthe 962 breast subjects, shown on Table 1, reflects a 
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middle aged (455 (47%)) aged between 40-49 years, with only 36 (4%) subjects between 
18-39 years of age and 225 (23%) over the age of 60), racially diverse (344 (36%) Black, 
317 (33%) Hispanic and 287 (30%) white and 249 (26%) Spanish speaking, and 173 
( 18%) "other" language speaking) population who are insured through a public program 
such as Medicaid (352, 37%) or uninsured (340, 35%). 
The demographic characteristics of the cervical subjects, also shown on Table 1, reflects 
a young (378/69% aged between 18-29 years), racially diverse (272/49% white, 121/ 
22% black and 113/21% Hispanic and 466/85% English speaking) population who is 
insured (231 ( 42%) privately insured, 213 (39%) publically insured). 
Tables 2 and 3 display our outcome of interest, distance to care, by demographic 
characteristics for breast and cervical subjects, respectively. As seen on Table 2, distance 
to care differed across subject race/ethnicity, primary spoken language, level of 
insurance, and the percent of population living below the Federal Poverty Level within 
their census tract. Those who live closer to Boston Medical Center were significantly 
more likely to be black, speak English or Spanish as a primary language, have public 
insurance such as Medicare or Medicaid, and live in a census tract where more than 23% 
of the population's income falls below the Federal Poverty Level. Those living farther 
from Boston Medical Center were significantly more likely to be white (mean distance of 
4.97 vs. 3.51 miles for black subjects, p<0.0001), primarily speak a language other than 
English or Spanish (median distance of 5.03 miles vs. 4.18 for English and 4.10 for 
Spanish, p<0.0001), have privately funded insurance (median distance of 4.63 miles for 
private vs. 4.10 for public insurance, p=0.0275), and live in a census tract where less than 
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10% of the population's income falls below the Federal Poverty Level (median distance 
of 5.78 miles vs. 3.34 for >25% p<0.0001). There were no significant differences in 
distance to Boston Medical Center by subject age category or type of breast screening 
abnormality. 
Subject Characteristics by Distance to Care. As seen on Table 3, for cervical screening 
subjects distance to community health center differed across subject age category, 
race/ethnicity, and the percent of population within their census tract whose income falls 
below the Federal Poverty Level. Those who live closer to their Community Health 
Center were significantly more likely to be over age 60, white, and live in census tract 
where more than 25% of the population's income falls below the Federal Poverty Level. 
Those living farther from their Community Health Center were significantly more likely 
to be younger than age 50 (, black or Hispanic, and live in a census tract where less than 
10% ofthe population's income falls below the Federal Poverty Level. There were no 
significant differences in distance to Community Health Center by primary spoken 
language, index of cervical screening abnormality, or level of insurance. 
Because the location to which women were referred for diagnostic follow-up varied by 
type of screening abnormality, the distance between breast subject's residence and 
Boston Medical Center was longer (mean 5.7 miles, median 4.6 miles, and range 0.4 to 
76 miles) than the distance between cervical subject's residence to the Community Health 
Center where they sought care (mean 4.1 miles, median 2.1 miles, and range 0.03 to 36 
miles). Despite the longer distances for breast screening subjects, the time to diagnostic 
resolution was longer for breast screening subjects (mean 47 days, median 31 days) than 
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for cervical screening subjects (mean 100 days, median 72 days) and at 365 days, only 
75% of cervical screening subjects had diagnostic resolution compared to 91% of breast 
screening subjects. 
Unadjusted Models. To assess the relationship between proximity from residence to 
clinical care and time to resolution, we plotted the distance to Boston Medical Center 
against the number of days to diagnostic resolution for each of the breast subjects, shown 
on Figure 1. If there was a linear relationship, the data would plot along a diagonal line. 
However, as seen in Figure 1, the data reflect a random association. Furthermore, the 
array of women who did not achieve diagnostic resolution, observed on the far right 
margin of Figure 1, reflect a range of distances to care from 1.5 to 28 miles. 
We also plotted the distance to their Community Health Center from their residence 
against the number of days to diagnostic resolution for cervical screening subjects, shown 
on Figure 2, to assess the relationship between proximity from residence to clinical care 
and time to resolution. Similar to the breast screening subjects, the data reflect a random 
association and the array of women who did not achieve diagnostic resolution observed 
on the far right margin of Figure 2 reflect a range of distances from 0.03 to 34 miles. 
Adjusted Models. To further assess the relationship between proximity from residence to 
clinical care and time to resolution for cervical screening subjects adjusting for 
covariates, we calculated adjusted hazard ratios (aHRs) for the proportional hazards 
model for the breast and cervical screening, which are presented on Tables 4 and 5, 
respectively. Hazard ratios greater than 1 are associated with improved time to definitive 
diagnosis. These models show no significant difference in timely resolution based on 
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continuous distance in 1,000 meter (0.62 mile) units (aHR 0.99; 95%CI 0.98,1.01 and 
aHR 1.02 95% CI 0.99, 1.05, respectively). The models adjusted for covariates including 
age, race language, severity of screening abnormality, insurance, percent of their census 
tract living below Federal Poverty Level (FPL) and for clustering within Community 
Health Centers. 
In the breast model, shown on Table 4, several covariates were associated with delays 
including insurance, compared to subjects with private insurance, subjects with public 
(aHR 0.65; 95%CI 0.54, 0.77) or no insurance (aHR 0.71; 95%CI 0.59, 0.86) had less 
timely diagnostic resolution. Race/ethnicity, speaking a language other than English, and 
percentage of census tract having an income below the Federal Poverty Level were not 
predictors of timely diagnostic resolution. Compared with subjects aged 41-64 years old, 
those aged 18-40 years old were more likely to have timely resolution (aHR 1.39 95%CI 
1.10,1.76) while there was no difference for those aged over 65 years (aHR 1.00; 95%CI 
0.82, 1.23). Index ofbreast screening abnormality compared to BIRADS 0 varied, 
subjects with BIRADS 3 and 4/5 abnormalities were initially more likely to have timely 
resolution, (aHR 19.5; 95%CI 9.86, 38.7) and (aHR 5.58; 95%CI 1.21 , 25 .6), 
respectively, but these findings decayed over time, crossing 1 at day 19 for BIRADS 3 
and BIRADS 4/5 on day 31. Subjects with a clinical breast abnormality (BIRADS 11 2) 
were less likely to have timely resolution (aHR 0.54; 95%CI 0.33 , 0.89). 
In the cervical model, shown on Table 5, no covariates were associated with either 
delays or improved time to diagnostic resolution with all 95% confidence intervals 
crossing 1 and p-values ranging from 0.0651 to 0.8086. 
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Discussion 
In this racial and ethnically diverse population of women participating in cancer 
screening at urban community health centers, we observed a lack of a correlation between 
proximity of residential address to site of care and time to diagnostic resolution. In 
addition, we did not observe a correlation between proximity to site of care and time to 
diagnostic resolution whether the subjects were referred to a clinic where they had 
previously been seen or to a different diagnostic clinic. These findings suggest that, in 
keeping with the Andersen's behavioral model of health services, the complexity of 
barriers to care and cancer health disparities is not moderated simply by the 
environmental factor of proximity to care. This finding is relevant for practitioners at 
community health centers who provide cancer screening to urban women at risk for 
health disparities and are concerned about distance as a factor in deciding where to refer 
patients for diagnostic care. 
While previous studies had identified environmental factors including neighborhood and 
spatial access to care as significant in the uptake of care and outcomes(20, 22, 28-30). 
Our findings are consistent with two studies undertaken in urban settings in which spatial 
access to care was not associated with stage at diagnosis or uptake of screening for breast 
cancer (15, 31) and suggest that system and individual-level factors may have a stronger 
influence on timely diagnosis as has been shown in other literature(4, 5, 11-13, 28, 30, 
32-39). 
First, in the control arm ofthis intervention study, we found significant delays in 
diagnostic care. For cervical screening subjects the mean time to diagnostic resolution 
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was 100 days and by day 365 only 75% had achieved diagnostic resolution. These delays 
are worse than a previous study to identify predictors of timely follow up within this 
population had found, where by day 365, 93% of Pap test abnormalities had been 
diagnostically resolved(39). The delay for breast patients, with a mean time to diagnostic 
resolution of 47 days and 91% of subjects achieving diagnostic resolution by day 365, is 
consistent with the previous study(39). Given that the previous study found that the only 
significant predictor of timely follow-up was the site of care, and our lack of an 
association with proximity to care, this suggests that system-level factors may have a 
larger impact on delays in care than environmental factors such as distance to care. 
Secondly, the women in this study were actively engaged in care having had a cancer 
screening test at a CHC, which has been shown to be associated with better uptake of 
recommended care (32, 35). Finally, other individual-level barriers to care that were not 
included in these analyses, such as financial barriers, may better predict delays in 
diagnostic resolution. 
Another potential reason for the observed lack of correlation between proximity to site of 
care and delays in diagnostic resolution include that in this urban population at least 75% 
of the study population lived within 5 miles of their site of care. Previous studies that 
found an association between distances to care and later stage at diagnosis (17, 22) 
typically found an association with distances greater than 5 miles. 
This study has several strengths, including the diverse study population at increased risk 
of cancer health disparities. For reference, the overall demographics for the city of 
Boston population based on the 2010 US Census were 54% white, 24% black and 18% 
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Hispanic, with 36% speaking a language other than English at home( 40). In addition, the 
study looked at control subjects from six different community health centers serving 
different ethnic communities so findings do not reflect one practice or ethnic community. 
In addition, access to longitudinal data for large numbers of urban subjects at risk for 
cancer health disparities who in previous studies were shown to have increased likelihood 
of delayed follow-up care makes this study unique from other studies which relied on 
epidemiological data(4, 5, 15, 17-19, 21-24, 29-33 , 38, 41 , 42). 
This study was limited by the lack of patient-reported data. Self-reported data on the type 
and number of barriers was not captured for control subjects of the Boston PNRP. In 
addition data including transportation options available to and used by subjects to get to 
their appointments, what factors were important to them in choosing care (proximity to 
home, proximity to work, or other factor) , and information for subjects who chose to seek 
follow-up care at an institution other than BMC or their community health center were 
not captured. 
In summary, understanding cancer health disparities and issues around access to care is 
more complex than merely distance to care. While increased distance to diagnostic care 
may increase the difficulty of receiving timely care in some settings; proximity of 
residential address to site of care was not correlated to time to diagnostic resolution for 
this at-risk urban population. Future work should identify system and individual-level 
factors impacting access to care for this urban disadvantaged population, especially for 
those who are not engaged in health care, because increased spatial access to health care 
16 
without addressing these other factors may not contribute to reducing cancer health 
disparities. 
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Table 1. Demographic Characteristics ofBreast and Cervical Screening Subjects. 
Characteristic Breast Subjects Cervical Subjects 
N=962 N=550 
Age 18-29 5 (0.5%) 378 (69%) 
(Decades) 30-39 31 (3%) 109 (20%) 
40-49 455 (47%) 42 (8%) 
50-59 246 (26%) 12 (2%) 
60-69 146(15%) 4 (0.7%) 
70-79 59 (6%) 4 (0.7%) 
80+ 20 (2%) 1 (0.2%) 
Race/Ethnicity White 287 (30%) 272 (49%) 
Black 344 (36%) 121 (22%) 
Hispanic 317 (33%) 113 (21 %) 
Other 14 (1 %) 44 (8%) 
Language English 540 (56%) 466 (85%) 
Spanish 249 (26%) 38 (7%) 
Other 173 (18%) 46 (8%) 
Insurance Private 270 (28%) 231 (42%) 
Type Public 352 (37%) 213 (39%) 
Uninsured 340 (35%) 106 (19%) 
%Census <10% 236 (25%) 219 (40%) 
Tract 10-15% 228 (24%) 35 (6%) 
Population 15-20% 162 (17%) 59 (11%) 
below FPL a 20-25% 163 (17%) 75(14%) 
>25% 169 (18%) 160 (29%) 
bCHC 1 347 (36%) 
2 156 (28%) 
3 501 (52%) 
4 114 (12%) 
5 265 (48%) 
6 129 (23%) 
Index of CBAc (Birads 1/ 2) 19 (2%) 
Abnormality Birads 0 788 (82%) 
Birads 3 140 (15%) 
Birads 4/5 15 (2%) 
Low Grade 513 (95%) 
High Grade 28 (5%) 
Categorical variables: N (% ). 
aFPL: Federal Poverty Level. bCHC: Community Health Center 
cCBA: Clinical Breast Abnormality. --:No Data 
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Table 2. Demographic Characteristics of Breast Screening Subjects by Distance in Miles 
to Boston Medical Center 
Characteristic Mean± SDa Median (IQR ) Range p-value 
Subject Age 18-29 4.6 ± 1.0 4.3 (4.1-4.7) 3.9 6.2 0.7344 
Category 30-39 4.6 ± 3.4 3.6 (3.1-5.3) 0.46 17 
40-49 5.4 ± 5.3 4.3 (3.2-5.8) 0.34 72 
50-59 5.7 ± 5.5 4.4 (3.1-5.9) 0.42 36 
60-69 5.3 ± 3.3 4.6 (3.4-6.0) 0.73 17 
70-79 5.4 ± 4.3 4.3 (2.9-5.8) 1.4 27 
80+ 6.0±4.5 4.2 (3.3-5.7) 2.6 18 
Subject Race/ White 6.1 ± 4.8 5.0 (3.6-6.2) 0.35 36 <0.0001 
Ethnicity Black 4.9± 4.0 3.5 (2.6-5.4) 0.39 30 
Hispanic 5.3 ± 5.7 4.4 (3 .3-5.6) 0.34 72 
Other 6.9 ± 7.0 4.0 (3 .5-6.1) 2.8 27 
Language English 5.2 ± 4.4 4.2 (3.0-5.7) 0.35 36 <0.0001 
Spanish 5.2 ± 6.2 4.1 (3.2-5.5) 0.34 72 
Other 6.4 ± 4.5 5.0 (3.5-6.8) 0.85 29 
Insurance Private 5.8 ± 5.3 4.6 (3.4-5 .9) 0.76 36 0.0275 
Public 4.8 ± 3.4 4.1 (3.0-5 .6) 0.34 27 
Uninsured 5.7 ± 5.9 4.5 (3 .2-6.0) 0.39 72 
% Census Tract <10% 8.6 ± 7.4 6.1 (4.1-10) 1.2 58 <0.0001 
Population 10-15% 5.5 ± 2.6 5.1 (4.2-6.0) 0.80 19 
below FPL d 15-20% 5.3±6.1 4.1 (3.6- 6.1) 0.96 76 
20-25% 4.1 ± 2.3 3.6 (2.8-5.9) 0.85 18 
>25% 3.7 ± 3.2 3.2 (2.1-4.4) 0.36 31 
Breast CBA c (Birads 1/2) 5.3 ± 3.4 4.3 (3 .3-6.2) 2.5 18 0.7925 
Abnormality Birads 0 5.5 ± 5.2 4.4 (3.2-5 .9) 0.34 72 
Birads 3 4.9 ± 3.6 4.3 (3.0-5.6) 0.42 29 
Birads 4/5 4.8± 2.8 4.3 (3.3-5 .3) 0.95 12 
a SD: standard deviation 
b IQR: Inter Quartile Range 
c CBA: Clinical Breast Abnormality 
d FPL: Federal Poverty Level 
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Table 3. Demographic Characteristics of Cervical Screening Subjects by Distance in 
Miles to Their Community Health Center 
Characteristic Mean± SDa Median (IQR 6) Range p-value 
Subject Age 18-29 4.0± 7.8 1.3 (0.54-4.6) 0.03 85 0.0451 
Category 30-39 3.3 ± 4.5 1.5 (0.68-4.1) 0.05 26 
40-49 5.6± 7.3 1.9 (0.99-8.6) 0.08 36 
50-59 1.8±2.4 0.85 (0.48-2.5) 0.03 7.1 
60-69 1.0 ± 1.3 0.41 (0.20-1 .8) 0.17 2.9 
70-79 0.68 ± 0.24 0.63 (0.51-0.85) 0.45 1.0 
80+ 0.33 0.33 0.33 0.33 
Subject White 4.1 ± 8.4 0.98 (0.46-4.6) 0.03 85 0.027 
Race/ Black 4.6± 7.3 2.0 (0.91-5.2) 0.05 42 
Ethnicity Hispanic 2.9± 3.8 1.7 (0.75-3.7) 0.03 31 
Other 3.2 ± 3.6 1.0 (0.57-5.3) 0.05 13 
Language English 4.0 ± 7.5 1.2 (0.55-4.6) 0.03 85 0.7782 
Spanish 2.5 ± 2.8 1.5 (0.99-3.5) 0.03 16 
Other 4.0 ± 5.1 1.4 (0.56-5. 7) 0.05 26 
Insurance Private 4.3 ± 9.2 1.1 (0.52-4.6) 0.03 85 0.321 
Public 3.5 ± 5.2 1.5 (0.56-4.4) 0.05 42 
Uninsured 3.7 ±4.7 1.8 (0.64-5 .00) 0.08 26 
%Census <10% 5.7± 10 1.0 (0.47-7.8) 0.04 89 <0.0001 
Tract 10-15% 6.2 ± 4.1 4.9 (3.8-6.5) 1.3 16 
Population 15-20% 3.4 ± 3.2 2.1 (1.0-5 .0) 0.37 17 
below FPL c 20-25% 2.3 ± 3.0 1.2 (0.90-2.6) 0.09 18 
>25% 2.4 ±5.5 1.1 (0.46-2.5) 0.03 44 
Cervical Low Grade 3.8 ± 7.1 1.3 (1.6-4.6) 0.03 85 0.8152 
Abnormality High Grade 4.5 ± 8.7 1.5 (0.43-4.6) 0.03 42 
a SD: standard deviation 
b IQR: Inter Quartile Range 
c FPL: Federal Poverty Level 
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Table 4. Cox Proportional Adjusted Hazard Ratios for Time to Diagnostic Resolution for 
Subjects with an Abnormal Breast Screening Exam 
Variable Level aHRa (95% CI) p-value 
Continuous Distance from 1,000 meter units 0.99 (0.98, 1.01) 0.4677 
Boston Medical Center (0.62 miles) 
Race/Ethnicity African-American 1.05 (0.79, 1.40) 0.7173 
Hispanic 0.91 (0.68, 1.22) 0.5454 
Other Race 1.24 (0.72, 2.15) 0.4352 
Age Category 18-40 years old 1.39 (1.10, 1.76) 0.0060 
>=65 years old 1.00 (0.82, 1.23) 0.9721 
Language Spanish 1.17 (0.88, 1.57) 0.2788 
Other Language 0.84 (0.69, 1.03) 0.0988 
% Population below FPL b Census Tract 1.01 (1.00, 1.01) 0.1252 
Insurance Public 0.65 (0.54, 0.77) 0.2788 
Index Stage CBA (Birads 1/2) 0.54 (0.33 , 0.89) 0.0151 
Birads 3 19.5 (9.86, 38.7) <0.0001 
Birads 3 x log(time_res) 0.36 (0.29, 0.44) <0.0001 
Birads 4/5 5.58 (1.21 , 25.6) 0.0272 
Birads 4/5 x log(time_res) 0.60 (0.38, 0.94) 0.0267 
Community Health Center CHC 1 1.04 (0.79, 1.36) 0.7972 
CHC4 4.01 (2.17, 7.42) <0.0001 
CHC4x log(time_res) 0.75 (0.63, 0.90) 0.0021 
Reference Group: White, 41-64 yrs old, English speaking, uninsured, BIRADS 0, CHC 3 
a aHR- Adjusted Hazard Ratio 
b FPL- Federal Poverty Level 
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Table 5. Cox Proportional Adjusted Hazard Ratios for Time to Diagnostic Resolution for 
Subjects with an Abnormal Cervical Cancer Screening Exam 
Variable Level 
Continuous Distance from 1,000 meter units 
Community Health Center (0.62 miles) 
Race/Ethnicity African-American 
Hispanic 
Other Race 
Age Category 18-40 years old 
>=65 years old 
Language Spanish 
Other Language 
% Population below FPL b Census Tract 
Insurance Public 
Index Stage High Grade 
Abnormality 
aHRa (95% CI) 
1.01 (1.00, 1.02) 
1.22 (0.87, 1.70) 
1.16 (0.81 ' 1.67) 
1.37 (0.86, 2.18) 
0.76 (0.54, 1.05) 
0.91 (0.73, 1.15) 
1.15 (0. 75, 1. 76) 
1.17 (0.78, 1.75) 
1.0 (0.99, 1.01) 
0.89 (0.70, 1.14) 
1.40 (0.92, 2.13) 
p-value 
0.065 
0.2587 
0.4140 
0.1796 
0.0969 
0.4295 
0.5257 
0.4515 
0.8086 
0.3550 
0.1115 
Community Health Center CHC 5 1.41 (1.03, 1.93) 0.0318 
CHC6 0.10 (0.02, 0.39) 0.0010 
CHC6x log(time res) 1.79 (1.32, 2.43) 0.0002 
Reference Group: White, 21-30 yrs old, English speaking, Uninsured, Low Grade 
a aHR- Adjusted Hazard Ratio 
b FPL- Federal Poverty Level 
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Figure 1. Plot of Distance to Boston Medical Center and Time to Diagnostic Resolution 
for Subjects with an Abnormal Breast Cancer Screening Exam 
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Figure 2. Plot of Distance to Community Health Center and Time to Diagnostic 
Resolution for Subjects with an Abnormal Cervical Cancer Screening Exam 
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